Reports for PFIZER CANADA ULC
Company Name
PFIZER CANADA ULC
Totals |
||
Shortage reports |
740 |
|
Actual shortage: | 85 (11%) | |
Anticipated shortage: | 6 (1%) | |
Avoided shortage: | 48 (6%) | |
Resolved: | 601 (81%) | |
Discontinuation Reports |
84 |
|
To be discontinued: | 1 (1%) | |
Discontinued: | 82 (98%) | |
Reversed: | 1 (1%) | |
Late reports |
17 (2%) |
|
Overdue reports |
9 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
LEUCOVORIN CALCIUM INJECTION USP | 10MG | SOLUTION | Resolved | 2022-01-19 | 2022-03-26 | 153077 |
SOLU-MEDROL | 500MG | POWDER FOR SOLUTION KIT | Resolved | 2022-02-03 | 2022-03-18 | 154141 |
CORVERT | 0.1MG | SOLUTION | Resolved | 2022-02-03 | 2022-03-16 | 154144 |
SOMAVERT | 10MG | POWDER FOR SOLUTION KIT | Resolved | 2022-02-03 | 2022-03-04 | 154158 |
VYNDAQEL | 20MG | CAPSULE | Resolved | 2022-01-12 | 2022-03-02 | 152609 |
ACCURETIC | 12.5MG 10MG | TABLET | Actual shortage | 2022-03-01 | 2022-03-02 | 155797 |
ACCURETIC | 12.5MG 20MG | TABLET | Actual shortage | 2022-03-01 | 2022-03-02 | 155800 |
ACCURETIC | 25MG 20MG | TABLET | Actual shortage | 2022-03-01 | 2022-03-02 | 155803 |
INDERAL-LA | 120MG | CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2022-02-24 | 2022-02-25 | 155568 |
INDERAL-LA | 160MG | CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2022-02-24 | 2022-02-25 | 155571 |
INDERAL-LA | 80MG | CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2022-02-17 | 2022-02-24 | 155253 |
INDERAL-LA | 60MG | CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2022-02-17 | 2022-02-24 | 155247 |
ROPIVACAINE HYDROCHLORIDE INJECTION USP | 5MG | SOLUTION | Resolved | 2022-01-27 | 2022-02-10 | 153749 |
METHOTREXATE INJECTION USP | 25MG | SOLUTION | Resolved | 2021-07-07 | 2022-02-10 | 141968 |
VFEND | 200MG | POWDER FOR SUSPENSION | Resolved | 2021-12-22 | 2022-02-05 | 151750 |
PROVERA 5MG TABLETS | 5MG | TABLET | Resolved | 2021-12-06 | 2022-02-01 | 150547 |
ATIVAN | 2MG | TABLET | Resolved | 2021-11-30 | 2022-02-01 | 150219 |
PROVERA 10MG TABLETS | 10MG | TABLET | Resolved | 2021-12-06 | 2022-02-01 | 150550 |
PROVERA 2.5MG TABLETS | 2.5MG | TABLET | Resolved | 2021-12-06 | 2022-02-01 | 150553 |
LORAZEPAM INJECTION USP | 4MG | SOLUTION | Resolved | 2020-11-06 | 2022-01-25 | 127901 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
IMIPENEM AND CILASTATIN FOR INJECTION | Discontinued | 2018-08-14 | 2018-08-15 | 58106 | ||
PACLITAXEL FOR INJECTION | 6MG | SOLUTION | Discontinued | 2017-07-11 | 2018-02-01 | 15446 |
EPIRUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-07-11 | 2017-09-05 | 15441 |
HEPARIN SODIUM INJECTION USP | 1000UNIT | SOLUTION | Discontinued | 2017-03-13 | 2017-04-02 | 1448 |